{"title":"Distal infusion stomal enteroclysis: An effective technique to manage postoperative enterostomal output","authors":"Navin Kumar, Summi Karn, Aakansha Giri Goswami, Asish Das, Lena Elizabath David, Dhiraj Mallik, Jyoti Sharma, Sudhir Kumar Singh, Farhanul Huda, Somprakas Basu","doi":"10.1016/j.jviscsurg.2024.11.002","DOIUrl":"10.1016/j.jviscsurg.2024.11.002","url":null,"abstract":"<div><h3>Background</h3><div>High output enterostomy leads to malnutrition and fluid/electrolyte loss which may be challenging to manage despite dietary modification, anti-motility, anti-secretory drugs, and parenteral nutrition. Distal infusion stomal enteroclysis (DISE) is an alternative to restore nutritional deficit and replace parenteral nutrition in resource-limited settings where treatment cost and availability of trained nurses are limiting factors.</div></div><div><h3>Objective</h3><div>To assess the effectiveness and feasibility of DISE in managing postoperative enterostomal output.</div></div><div><h3>Methods</h3><div>Consecutive patients who met the inclusion criteria and underwent enterostomy in one year were included. Postoperatively, DISE was started after the return of bowel movement. Stomal effluent was collected, filtered, and reinfused through the distal limb using a Foley catheter. The patients and caregivers were trained to perform under supervision. At discharge, they were encouraged to maintain regular contact and advised to report back when necessary.</div></div><div><h3>Results</h3><div>Twenty-five patients received DISE, of which 22 were discharged and successfully continued to manage at home, while 3 expired. The median age was 36 years, the median BMI at admission and discharge was 19<!--> <!--> and 17.8<!--> <!-->kg/m<sup>2</sup> respectively (the difference was statistically significant), and the male: female ratio was 2.5: 1. Thirty-day readmission was done for 2 patients to manage minor complications. The average stomal output was 820<!--> <!-->mL/day initially and 478<!--> <!-->mL/day at discharge. The median duration of DISE was 12 days. Thirteen patients (52%) needed parenteral nutritional support due to inadequate oral intake.</div></div><div><h3>Conclusion</h3><div>DISE is a feasible and effective technique for managing high output enterostomies. It can be easily taught and performed with minimal resources at home.</div></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"162 1","pages":"Pages 13-18"},"PeriodicalIF":2.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Perineal and posterior vaginal wall reconstruction after abdominoperineal resection with two lotus petal flaps (with video)","authors":"Guillaume Henry, Frédéric Bodin","doi":"10.1016/j.jviscsurg.2024.07.011","DOIUrl":"10.1016/j.jviscsurg.2024.07.011","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"162 1","pages":"Pages 55-57"},"PeriodicalIF":2.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141890676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Position statement and guidelines about Endoscopic Sleeve Gastroplasty (ESG) also known as “Endo-sleeve”","authors":"Clément Baratte , Hugues Sebbag , Laurent Arnalsteen , Thomas Auguste , Marie-Cécile Blanchet , Salomon Benchetrit , Adel Abou-Mrad , Fabian Reche , Laurent Genser , Robert Caiazzo , Andrea Lazzati , Jean-Marc Catheline , Guillaume Pourcher , Pierre Leyre , Sandrine Kamoun-Zana , Fabien Stenard , Thibaut Coste , Adrien Sterkers , Claire Blanchard , Tigran Poghosyan , Maud Robert","doi":"10.1016/j.jviscsurg.2024.12.003","DOIUrl":"10.1016/j.jviscsurg.2024.12.003","url":null,"abstract":"<div><h3>Is ESG effective in the treatment of obesity and associatedcomorbidities?</h3><div>Endoscopic Sleeve Gastroplasty (ESG) is more effective than lifestyle modifications alone for weight loss and improving obesity-related comorbidities. While it has less effect on weight loss compared to Laparoscopic Sleeve Gastrectomy (LSG) in the short to medium term, it offers similar comorbidities resolution to LSG.</div></div><div><h3>Is ESG a safe procedure, and what are its risks?</h3><div>The safety profile of ESG is consistently supported in the literature. Surgical complications after ESG, ranging from 1.5 to 2.3%, such as bleeding, perforation, fistula, or upper bowel obstruction, are rare and typically managed endoscopically. The incidence of new-onset gastro-esophageal reflux disease (GERD) is deemed negligible and occurs less frequently after ESG compared to SG.</div></div><div><h3>What are the indications and management methods?</h3><div>Multidisciplinary care for patients undergoing ESG should be provided in an accredited center authorized to perform bariatric and metabolic surgery, with validation through a multidisciplinary consultation meeting (RCP). Perioperative management should be personalized and ideally modeled after the protocols already in place for bariatric and metabolic surgery to ensure satisfactory and lasting weight and metabolic outcomes. Adherence to follow-up visits is a significant predictor of successful weight loss outcomes after ESG. Additionally, all endoscopic surgical procedures should be documented in a registry affiliated with a recognized scientific society, as is standard for other bariatric surgical procedures.</div></div><div><h3>Which healthcare professionals can perform ESG?</h3><div>ESG must be performed by a practitioner trained in endoscopy and obesity management, capable of ensuring thorough preoperative care and comprehensive postoperative follow-up, supported by an experienced multidisciplinary team. In France, Notice No. 2021.0040/AC/SEAP of June 10, 2021, issued by the Haute Autorité de santé (HAS) college, specifies that “the technology of ESG via the trans-oral approach, involving wide plication of the greater gastric curvature […] with an endoscopic suture placement device, enables a gastroenterologist or a visceral and digestive surgeon to perform gastric plication through digestive endoscopy by placing sutures in the stomach”. Ideally, this should take place in an accredited center authorized to perform bariatric and metabolic surgery, such as those approved by the Agence régionale de santé (ARS), in accordance with Article R6123-212 of December 2022 of the French Public Health Code.</div></div><div><h3>What are the recommendations and views of other international scientificsocieties?</h3><div>ESG is an integral part of the therapeutic arsenal available to bariatric and metabolic surgeons, offering an effective and valuable treatment option for obesity in specific patient populations. The Inter","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"162 1","pages":"Pages 71-78"},"PeriodicalIF":2.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142967187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Acknowledgements to our reviewers","authors":"","doi":"10.1016/j.jviscsurg.2025.02.003","DOIUrl":"10.1016/j.jviscsurg.2025.02.003","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"162 1","pages":"Page 1"},"PeriodicalIF":2.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143480096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy of CycloMesh™ + Ropivacaine in the treatment of uncomplicated inguinal hernia after the Lichtenstein procedure: Results of a prospective multicentric double-blind study","authors":"Frank-Olivier Breleur , Haitham Khalil , André Dabrowski , Francois Mauvais , Irakli Pipia , Mathieu Messager , Mégane Homa , Jean-Marc Regimbeau","doi":"10.1016/j.jviscsurg.2024.11.006","DOIUrl":"10.1016/j.jviscsurg.2024.11.006","url":null,"abstract":"<div><h3>Background</h3><div>Twenty to 30% of patients undergoing inguinal hernia surgery (20 million patients per year worldwide) present early postoperative pain. The aim of this study was to assess the interest of a mesh (CycloMesh™, Cousin Biotech) soaked with ropivacaine for managing early postoperative pain.</div></div><div><h3>Materials and methods</h3><div>This was a randomized, phase III, comparative superiority, double-blind, international multicenter study. From October 2019 to February 2022, 290 patients underwent surgery for uncomplicated inguinal hernia, under general anesthesia, using the Liechtenstein technique. Each patient was randomly assigned to either the experimental group (mesh soaked in ropivacaine hydrochloride 10<!--> <!-->mg/mL) or the control group (mesh soaked in physiological saline solution). The primary endpoint was the pain at cough assessment with the visual analogue scale (VAS) at H6 after the surgery. The secondary endpoints were the global pain assessment at H2, H4, H6, day 1, day 2, day 3, day 7, 1<!--> <!-->month, 1<!--> <!-->year, and 2<!--> <!-->years after the surgery, assessment of antalgic consumption, description of the surgical procedure and postoperative complications rate, hospitalization and post-hospital discharge data (number of conversions from outpatient to inpatient care), and recurrence.</div></div><div><h3>Results</h3><div>Of the 290 patients included in the study, 150 and 140 patients were in the experimental or control group respectively. The per-protocol (PP) population (240 patients) comprised 125 patients in the ropivacaine group and 115 in the control group. The mesh soaking solution had no significant effect on the pain at cough at H6, either in the intention-to-treat population (3.3 vs 3.2, <em>P</em> <!-->=<!--> <!-->0.12) or in the PP population (3.3 vs 3.7, <em>P</em> <!-->=<!--> <!-->0.15). The ropivacaine-soaked prosthesis resulted in a reduction in overall pain at H2 (2.3 vs 3.2, <em>P</em> <!--><<!--> <!-->0.0001), H4 (2.3 vs 3.1, <em>P</em> <!--><<!--> <!-->0.0001) and H6 (2.3 vs 2.7, <em>P</em> <!-->=<!--> <!-->0.0039). There was no difference between the two groups in terms of antalgic consumption, postoperative complications, or the number of ambulatory conversions.</div></div><div><h3>Conclusion</h3><div>The placement of CycloMesh™ soaked with ropivacaine did not reduce the pain at cough at H6 but did reduce overall pain in the first 6<!--> <!-->hours after surgery and could simplify patient management.</div></div>","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"162 1","pages":"Pages 19-30"},"PeriodicalIF":2.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clément Louis-Gaubert, Bastien Le Floc’h, Heithem Jeddou
{"title":"Laparoscopic left hepatectomy (with video)","authors":"Clément Louis-Gaubert, Bastien Le Floc’h, Heithem Jeddou","doi":"10.1016/j.jviscsurg.2024.09.004","DOIUrl":"10.1016/j.jviscsurg.2024.09.004","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"162 1","pages":"Pages 65-68"},"PeriodicalIF":2.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142299464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Quentin Chenevas-Paule, Pierre-Yves Sage, Mircea Chirica
{"title":"Management of Boerhaave syndrome by right thoracoscopy in prone position (with video)","authors":"Quentin Chenevas-Paule, Pierre-Yves Sage, Mircea Chirica","doi":"10.1016/j.jviscsurg.2024.09.002","DOIUrl":"10.1016/j.jviscsurg.2024.09.002","url":null,"abstract":"","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":"162 1","pages":"Pages 61-64"},"PeriodicalIF":2.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}